Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA. (Q38333058)

2 September 2017

1 reference

title

Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA. (English)

1 reference

2 September 2017

1 reference

Marawan Ahmed

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Feng Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Aviad Levin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Connie Le

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Yomna Eltayebi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Lorne Tyrrell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

24 January 2015

1 reference

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

548-561

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

Infection of a human hepatoma cell line by hepatitis B virus

1 June 2020

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.232137699

Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

NTCP and beyond: opening the door to unveil hepatitis B virus entry

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Structural basis of the TAL effector-DNA interaction

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

APOBEC3 proteins mediate the clearance of foreign DNA from human cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Engineered external guide sequences are highly effective in inhibiting gene expression and replication of hepatitis B virus in cultured cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Structural organization of the hepatitis B virus minichromosome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

New developments in antiviral therapy for chronic hepatitis B.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Viruses and interferons

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

New therapeutic targets and drugs for the treatment of chronic hepatitis B.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Interferon in hepatitis B

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Activation and signaling of the p38 MAP kinase pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Targeted cleavage of mRNA by human RNase P

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Synthesis and antiviral activity of helioxanthin analogues

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

DNA double-strand break repair: all's well that ends well

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

HBV life cycle: entry and morphogenesis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Engineered external guide sequences effectively block viral gene expression and replication in cultured cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

External Guide Sequences for an RNA Enzyme

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Antiviral therapy of chronic hepatitis B: prevention of drug resistance.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus replication

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

PGC-1alpha controls hepatitis B virus through nutritional signals

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Native hepatitis B virions and capsids visualized by electron cryomicroscopy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

CpG islands and the regulation of transcription

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Mechanisms of gene silencing by double-stranded RNA

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Mutations altering the cleavage specificity of a homing endonuclease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

In vitro hepatitis B virus infection of human bone marrow cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Methylation regulates hepatitis B viral protein expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Computational redesign of endonuclease DNA binding and cleavage specificity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Risk stratification for hepatitis B virus related hepatocellular carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

A species of small antisense RNA in posttranscriptional gene silencing in plants

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

A review of non-nucleoside anti-hepatitis B virus agents

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Inhibition of hepatitis B virus gene expression and replication by ribonuclease P.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Identification of new qingyangshengenin and caudatin glycosides from the roots of Cynanchum otophyllum

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Characterization of the host factors required for hepadnavirus covalently closed circular (ccc) DNA formation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Small interfering RNA for effective cancer therapies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

In vitro model for the nuclear transport of the hepadnavirus genome.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Nuclear export and import of human hepatitis B virus capsid protein and particles

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Engineering domain fusion chimeras from I-OnuI family LAGLIDADG homing endonucleases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Caudatin-2,6-dideoxy-3-O-methy-β-D-cymaropyranoside 1 induced apoptosis through caspase 3-dependent pathway in human hepatoma cell line SMMC7721.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

FokI dimerization is required for DNA cleavage

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

TALENs: a widely applicable technology for targeted genome editing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis viruses and the MAPK pathway: is this a survival strategy?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Proteins of hepatitis B surface antigen: amino acid compositions of the major polypeptides

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus infection--natural history and clinical consequences

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

siRNAs: applications in functional genomics and potential as therapeutics

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Risks of chronicity following acute hepatitis B virus infection: a review

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus subgenotyping: history, effects of recombination, misclassifications, and corrections.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Targeted delivery of siRNA against hepatitis B virus by preS1 peptide molecular ligand

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

In vitro selection of external guide sequences for directing RNase P-mediated inhibition of viral gene expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Virology. Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

FLASH assembly of TALENs for high-throughput genome editing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymerase

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Interferon therapy for chronic hepatitis B.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Structural Basis for Sequence-Specific Recognition of DNA by TAL Effectors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Selection of guide sequences that direct efficient cleavage of mRNA by human ribonuclease P.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Targeted gene knockout by direct delivery of zinc-finger nuclease proteins

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B viruses: reverse transcription a different way.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus encoded X protein suppresses apoptosis by inhibition of the caspase-independent pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Xanthomonas AvrBs3 family-type III effectors: discovery and function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Three-dimensional solution structure of a single zinc finger DNA-binding domain

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

A C 21 -Steroidal Glycoside Isolated from the Roots of Cynanchum auriculatum Induces Cell Cycle Arrest and Apoptosis in Human Gastric Cancer SGC-7901 Cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Inhibition of hepatitis B virus expression and replication by RNA interference

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Assembly and function of RNA silencing complexes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Caudatin induces cell cycle arrest and caspase-dependent apoptosis in HepG2 cell

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Control of cccDNA function in hepatitis B virus infection.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Targeted DNA mutagenesis for the cure of chronic viral infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Hepatitis B virus biology

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

How further suppression of virus replication could improve current HBV treatment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

The beta-beta-alpha fold: explorations in sequence space

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Synthesis and biological evaluation of helioxanthin analogues

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

TAL effectors: function, structure, engineering and applications

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Acetylation of histones and transcription-related factors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Liposomal siRNA delivery

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

TALENs targeting HBV: designer endonuclease therapies for viral infections.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Regulatory elements of hepatitis B virus transcription

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Small-molecule inhibitors for the treatment of hepatitis B virus documented in patents

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Zinc fingers: a novel protein fold for nucleic acid recognition

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Treatment of hepatitis B virus infection with interferon. Factors predicting response to interferon

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Caudatin inhibits carcinomic human alveolar basal epithelial cell growth and angiogenesis through modulating GSK3β/β-catenin pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2015.01.008

Identifiers

DOI

10.1016/J.DRUDIS.2015.01.008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25622780%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference